Listed

Emergent BioSolutions Inc.

EBSNYSECIK 1367644HealthcareFiscal year ends Dec 31

Reports and events: 405 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Emergent BioSolutions Inc., Reports and events
FiledFormWhat it isAccession number
2018-08-0317:55 ET10-QQuarterly reportPeriod 2018-06-300001367644-18-000033
2018-08-0216:59 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001367644-18-000032
2018-05-2416:21 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results0001367644-18-000025
2018-05-0416:04 ET10-QQuarterly reportPeriod 2018-03-310001367644-18-000023
2018-05-0316:34 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001367644-18-000016
2018-04-1321:48 ETDEF 14AProxy statementPeriod 2018-05-240001140361-18-018425
2018-03-2616:38 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-18-096017
2018-02-2318:00 ET10-KAnnual reportPeriod 2017-12-310001367644-18-000014
2018-02-2217:03 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001367644-18-000011
2018-02-1417:06 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001367644-18-000008
2018-01-1606:47 ET8-K2.02 Results of operations0001367644-18-000004
2018-01-0807:13 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001367644-18-000002
2017-11-1417:26 ET8-K3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001367644-17-000051
2017-11-0312:25 ET10-QQuarterly reportPeriod 2017-09-300001367644-17-000048
2017-11-0216:57 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001367644-17-000045
2017-10-0611:17 ET8-K2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001367644-17-000043
2017-10-0308:00 ET8-K2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001367644-17-000039
2017-10-0208:03 ET8-K1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001367644-17-000036
2017-08-0417:46 ET10-QQuarterly reportPeriod 2017-06-300001367644-17-000034
2017-08-0316:32 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001367644-17-000030
2017-07-2516:25 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001367644-17-000028
2017-07-1407:11 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001367644-17-000026
2017-05-2516:23 ET8-K5.07 Shareholder vote results0001367644-17-000024
2017-05-0518:09 ET10-QQuarterly reportPeriod 2017-03-310001367644-17-000022
2017-05-0416:22 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001367644-17-000019
2017-04-1316:04 ETDEF 14AProxy statementPeriod 2017-05-250001193125-17-123208
2017-03-1709:13 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001367644-17-000017
2017-02-2820:38 ET10-KAnnual reportPeriod 2016-12-310001367644-17-000014
2017-02-2317:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001367644-17-000008
2017-02-2117:09 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001367644-17-000005
2017-01-0908:09 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001367644-17-000003
2016-12-0817:27 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001367644-16-000084
2016-11-0917:39 ET10-QQuarterly reportPeriod 2016-09-300001367644-16-000082
2016-11-0816:35 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001367644-16-000080
2016-11-0716:50 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001367644-16-000078
2016-09-3009:21 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001367644-16-000076
2016-08-0516:28 ET10-QQuarterly reportPeriod 2016-06-300001367644-16-000074
2016-08-0417:25 ET8-K1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits0001367644-16-000071
2016-08-0416:55 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001367644-16-000070
2016-05-2009:30 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results0001367644-16-000066
2016-05-0613:42 ET10-QQuarterly reportPeriod 2016-03-310001367644-16-000064
2016-05-0516:21 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001367644-16-000061
2016-04-0816:25 ETDEF 14AProxy statementPeriod 2016-05-190001193125-16-535541
2016-02-2914:31 ET10-KAnnual reportPeriod 2015-12-310001367644-16-000059
2016-02-2516:27 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001367644-16-000057
2016-01-1107:13 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001367644-16-000055
2016-01-0416:48 ET8-K5.02 Departure or appointment of officers or directors0001367644-16-000053
2015-12-2216:26 ET8-K5.02 Departure or appointment of officers or directors0001367644-15-000051
2015-12-0416:28 ET8-K5.02 Departure or appointment of officers or directors0001367644-15-000049
2015-12-0116:31 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001367644-15-000045

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 4, 2026, 16:51 ET. Listed shows no prices and gives no investment advice.